About: Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 11 July 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xunetu de 2019 (ast) im Juli 2019 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована 11 липня 2019 (uk) 2019 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված (hy) scientific article published on 11 July 2019 (en)
publication date	wds:Q91792483-37FC2F92-A05F-4F1F-AFE0-8FBC175CFC4A
publication date	2019-07-11 00:00:00Z (xsd:dateTime)
author name string	wds:Q91792483-1FA3F34F-131B-4285-9BE8-3EA4E3982B9E wds:Q91792483-6064A26F-DABD-43CC-996E-FB9CCE6FF18F wds:Q91792483-6E9216C8-12D2-433B-BB79-33E82943DA22 wds:Q91792483-77E3BAA6-C343-428C-B839-35DF29DDB04B wds:Q91792483-9D145F22-ACF1-4E7B-BEAE-25E0B37D21D2 wds:Q91792483-ACD9908A-3910-495C-93EE-97913216357B wds:Q91792483-B19A59D3-607B-4AF5-BC47-284B0E8972C2 wds:Q91792483-B23E26B1-6087-4BF5-91AD-4F33ACF2F173 wds:Q91792483-D26EEAA1-E7DA-440A-A626-6C165F6314D3 wds:Q91792483-E171A780-8A56-49C3-A54C-FDA0BB5018FA wds:Q91792483-EF4F5442-A32B-466E-AEAA-E8D45479506B wds:Q91792483-FA6814E8-69CC-4906-B6D8-63916B05EBAD
author name string	Adrianus J de Langen Paul Baas Joachim G J V Aerts Kim Monkhorst Vincent van der Noort Idris Bahce Ferry Lalezari Daphne W Dumoulin Heike M U Peulen Willemijn S M E Theelen Jeltje F de Vries Anna-Larissa N Niemeijer
rdfs:label	Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (en) Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (nl)
skos:prefLabel	Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (en) Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (nl)
name	Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (en) Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (nl)
title	wds:Q91792483-7BA2BFEF-E0F8-42EE-904D-981ED7DB9DB1
title	Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial (en)
instance of	wds:Q91792483-C2C0E69D-401A-4DF4-8C63-D95DF04FC9F7
instance of	scholarly article
main subject	wds:Q91792483-19D8C4E3-9CB4-4341-810D-8C1B88E38503 wds:Q91792483-4A43051E-8F7E-44B7-85D7-967061630C52 wds:Q91792483-C11699AE-AAB3-417C-8A7A-8658036F95D6
main subject	pembrolizumab lung cancer phase II clinical trial
PubMed ID	wds:Q91792483-0B00DA9F-85EB-40E3-816D-897F3143D71D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31294749
PubMed ID	31294749
published in	wds:Q91792483-FFB1E4F8-FE87-41FD-AA78-F0A7C9F840AF
published in	JAMA Oncology
DOI	wds:Q91792483-82C4FDFB-3BFF-401D-B916-FF9DD391B23B
DOI	http://dx.doi.org/10.1001/JAMAONCOL.2019.1478
DOI	10.1001/JAMAONCOL.2019.1478
PMCID	wds:Q91792483-B0DAC76A-D8CE-4E64-A629-33AD16B810CE
PMCID	6624814
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91792483
is cites work of	The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells Radiotherapy-immunotherapy combinations - perspectives and challenges Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach? Enhancing the efficacy of immunotherapy using radiotherapy The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial SBRT combined with PD-1/PD-L1 inhibitors in NSCLC treatment: a focus on the mechanisms, advances, and future challenges Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination [Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer] Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies Impact of Systemic Therapy Type and Timing on Intracranial Tumor Control in Patients with Brain Metastasis from Non-Small Cell Lung Cancer Treated With Stereotactic Radiosurgery The PEMBRO-RT phase II randomized trial and the evolution of therapy for metastatic non-small cell lung cancer: a historical perspective Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study Local ablative radiotherapy for oligometastatic non-small cell lung cancer Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer Radiation therapy for augmenting the efficacy of immunotherapy in advanced non-small cell lung cancer: a case-controlled study Immune biological rationales for the design of combined radio- and immunotherapies Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response Combining immunotherapy and radiotherapy for the STAR treatment The abscopal effect 67 years later: from a side story to center stage An annual review of the remarkable advances in lung cancer clinical research in 2019 A first attempt to establish a definition of oligometastatic non-small cell lung cancer by a European consensus group Oligometastasis and local ablation in the era of systemic targeted and immunotherapy Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma Enhancing anti-tumour efficacy with immunotherapy combinations Combining immunotherapy and radiotherapy in lung cancer: a promising future?
is cites work of	wds:Q97540710-CDCBD2E6-F5D8-4340-87B4-A18B53602D6B wds:Q89950461-71199483-679D-4DEA-AEF2-85E2EC02756E wds:Q91587573-EDCF214E-87F6-4BC7-AA70-A535E4EFAF7B wds:Q100386707-BF305BD9-12E8-4AD6-BDEE-D0536F67902A wds:Q92715618-C9809DF8-0FD7-43E0-84C6-0EF938B48EC1 wds:Q99405188-419E7FB2-2FA9-4813-8059-27B103E9C9AC

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software